Australia's largest stock trading and investment forum Australia's #1 stock forum

When was the last time that if you didn't take an experimental...

First 103 Last

Share
Profile

Follow
crustymagyver

2,032 Posts.

258

22/12/21

15:48

Post #: 58465797
Share

Originally posted by vintage: ↑

You entirely missed the point I was making!

It was about the length/continuity of treatment. Seems many anti-vaxxers here are concerned about the NUMBER of treatments/jabs - like getting boosters at intervals of time after the initial jabs. But this ongoing need for treatments is COMMONPLACE - and no BIG deal.

Pays to comprehend what people are saying before knee-jerk reacting.

But to address your point, anyway, you don't seem to understand the pharmaceutical industry. EVERY drug is éxperimental' to some extent because they are all trialed on population samples, not entire populations. The complete epidemiology knowledge for EVERY drug is developed over the full life-cycle of the drug as use evolves over much larger populations.

All those cancer and heart drugs had a first day of release without any benefit of ýears of in-field use'. Their on-going efficacy and safety is then monitored for years. Many do not get 'many years of trials' if there is an urgent need to save lives. This is not the first time that drug trials have been fast-tracked!

You guys - because of your lack of understanding of detail - seem to have an endless supply of time-wasting red herrings!

Expand

When was the last time that if you didn't take an experimental drug you could not work, interact with others ,travel, open your business or leave your house?
8 Upvote

Reply

Top Stories

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

HotCopper Highlights: Your most watched stocks for Week 46, 2024

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

First 103 Last

When was the last time that if you didn't take an experimental...

Banshee's historic trenches prove rich in antimony and gold for GDM

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Cyclone signs MOU with Vale for development of Iron Bear play

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Featured News

Featured News

When was the last time that if you didn't take an experimental...

Top Stories

Banshee's historic trenches prove rich in antimony and gold for GDM

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Cyclone signs MOU with Vale for development of Iron Bear play

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Featured News

Featured News